Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Viramune triple RT therapy provides sustained reduction in HIV-1 RNA to undetectable levels

March 31, 1998

DuPont Merck searches for orally active cyclic urea HIV protease inhibitors

March 31, 1998

AIDS vaccine technologies available for licensing from NIH

March 27, 1998

Incyte identifies human monocyte chemotactic proprotein

March 27, 1998

FDA to review data from phase III trial of Alferon N Injection in HIV

March 26, 1998

Isis and Zeneca collaborate on oligonucleotide manufacturing; fomivirsen filing in sight

March 25, 1998

T-20 + efavirenz + protease inhibitors to be evaluated in HIV patients

March 20, 1998

Progenics' HIV products show promise in phase I/II clinical trials

March 20, 1998

Combivir approved in E.U.

March 19, 1998

Stavudine versus zidovudine therapy in HIV-1-infected pediatric patients

March 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...